Filing Details

Accession Number:
0001140361-17-037745
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-05 18:34:25
Reporting Period:
2017-10-03
Accepted Time:
2017-10-05 18:34:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1447028 Arbutus Biopharma Corp ABUS Pharmaceutical Preparations (2834) 980597776
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635324 J. Michael Sofia C/O Arbutus Biopharma Corp.
Suite 100, 8900 Glenlyon Parkway
Burnaby A1 V5J 5J8
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2017-10-03 10,000 $8.00 1,553,403 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 171,412 Indirect Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust").
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.